| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3867025 | The Journal of Urology | 2012 | 7 Pages |
Abstract
Renal cell carcinoma histological subtype predicts overall and cancer specific survival. Patients with collecting duct and sarcomatoid variants of renal cell carcinoma have poor survival, even those who present with low stage disease. These data suggest inherent differences in renal cell carcinoma biology and may ultimately form the basis of future histologically targeted therapies.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Kirk A. Keegan, Clayton W. Schupp, Karim Chamie, Nicholas J. Hellenthal, Christopher P. Evans, Theresa M. Koppie,